It just means placebo response was as good as NTCELL. Doesn't look like a pooled analysis would do anything either as some on NTCELL 120 were worse than baseline.
They will probably need to wait 1-2 years and hope everyone stays on the follow up protocol for the trial to wait for placebo to get worse but at that point hard to tell why placebo got worse compared to the NTCELL arm.
Disappointing all around. I've sold out today.
Ann: Results of LCT Parkinsons trial require further analysis, page-17
-
- There are more pages in this discussion • 147 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
